<span style="line-height: 18.9091px;">Thompson Street Capital Partners </span>sold some of its stake<span style="line-height: 18.9091px;">in BioreclamationIVT, a provider of biological research materials used in drug development, to Arsenal Capital Partners, Amy Or reports for LBO Wire.</span>